Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105820113A details a robust chiral resolution method for Crizotinib intermediates. This process ensures high purity, operational simplicity, and substantial cost reduction in pharmaceutical manufacturing.
Patent CN106008366A reveals microwave-assisted rilpivirine synthesis improving yield and reducing energy for reliable API manufacturing supply chains.
Advanced synthetic route for Epinastine intermediates using safe borohydride reduction, eliminating expensive silanes and toxic azides for cost-effective manufacturing.
Novel patent CN121405662A offers efficient route for thiophene sulfonyl compounds ensuring high purity and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN1298402A reveals a safer synthesis route for anti-arrhythmic agents, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115703796A reveals a high-yield route for Remdesivir intermediates using methylthio-substitution, offering significant cost reduction and supply chain stability for API manufacturing.
Patent CN115626947B reveals a novel Tempo-NaClO-KBr oxidation route for pentacyclic triterpenes. Achieve significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel serine-based route for methyl 2,3-diaminopropionate. Mild conditions, high yield, scalable process for peptidomimetic inhibitor manufacturing.
Novel serine-based route for methyl 2,3-diaminopropionate offers cost reduction and mild conditions for peptide inhibitor manufacturing.
Novel 10-step synthesis for Lobeline avoiding expensive catalysts. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for global markets.
Novel elimination method for high-purity 16-dehydroprogesterone. Cost-effective, scalable process for steroid drug manufacturing utilizing biphasic catalysis.
Patent CN108137530A details optical resolution for β-2-thienyl-alanine. Offers cost reduction and supply reliability for pharma intermediates.
Novel patent CN112724189B details waste-to-value synthesis enhancing supply chain reliability and cost efficiency for global pharmaceutical intermediate procurement strategies.
Patent CN109824539B details a novel 6-step Tigecycline synthesis from Demethyl Aureomycin, offering high purity, cost reduction, and scalable manufacturing for pharmaceutical intermediates.
Patent CN101180263B reveals a novel 3-step synthesis eliminating dimer impurities. Discover cost-effective manufacturing and stable salt forms for neurodegenerative disease therapeutics.
Patent CN1752086A reveals a mild, one-pot synthesis for Azelnidipine intermediates, offering high purity and cost reduction in calcium channel blocker manufacturing.
Patent CN1469864A details improved alkylation methods using phase transfer or buffered inorganic bases, enhancing yield and reducing costs for pharmaceutical intermediates.
Novel route for Gefitinib avoiding methanesulfonic acid demethylation, offering cost-effective API intermediate manufacturing solutions.
Patent CN101260116A details a cost-effective GCLE synthesis route using Penicillin G potassium salts, offering superior purity and scalability for cephalosporin manufacturing.
Patent CN105254648B reveals optimized cephalosporin route reducing steps and improving scalability for reliable supply chains globally. This method ensures high purity veterinary drug intermediates with simplified operational conditions for industrial partners.